Skip to main content

Table 3 Antimicrobial prescriptions and linezolid prescriptions. Data from the national point prevalence surveys 2011 and 2016. Data comparison of the two surveys

From: Linezolid use in German acute care hospitals: results from two consecutive national point prevalence surveys

Parameter Variable Specification Number (percentage) p-value
PPS 2011 PPS 2016
Antimicrobial prescriptions (all)    14,076 (100) 22,086 (100) n.a.
Linezolid prescriptions (all)    119 (0.8) 255 (1.2) < 0.01
Linezolid prescriptions (all wards) Total   119 (100) 255 (100) n.a.
Dosage 2 × 600 mg n.a. 227 (89.0) n.a.
All other dosages n.a. 28 (11.0)
Route of application Parenteral 87 (73.1) 179 (70.2) 0.57
Oral 32 (26.9) 76 (29.8)
Linezolid prescriptions in non-ICU wards Total   67 (56.3) 156 (61.2) n.a.
Route of application Parenteral 36 (53.7) 87 (55.8) 0.78
Oral 31 (46.3) 69 (44.2)
  1. P-values for variables were calculated using Chi-squared test. Bold print is used to indicate statistical significance. Abbreviations: PPS point prevalence survey, ICU intensive care unit, n.a. not available/not applicable